Kim K, Min CK, Koh Y, Ishizawa K, Kim SH, Ito S, Tanaka J, Uchiyama M, Kawano Y, Kim JS, Moreau P, Martin T, Dong Y, Risse ML, Suzuki K.

Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis.

Int J Hematol 116(4):553-562,2022.doi: 10.1007/s12185-022-03378-w.

https://pubmed.ncbi.nlm.nih.gov/35578151/